New cancer drugs are showing great promise
U.S. News & World Report: Doctors are now personalizing treatment paths according to the genetic code of a patient’s cancer. Some innovative treatments are occurring in clinical trials, which fewer than 10 percent of patients enroll in, according to Neal Meropol, professor of medicine. “We’re getting smarter about how clinical trials are designed, and how patients are selected. The likelihood of deriving a personal benefit from a clinical trial may actually be increasing.”